Table Of Contents

1. Introduction

1.1 Market Definition

1.2 Scope (Inclusion and Exclusions)

1.3 Research Assumptions

2. Executive Summary

2.1 Market Overview

2.2 Regional Synopsis

2.3 Competitive Summary

3. Research Methodology

3.1 Top-Down Approach

3.2 Bottom-up Approach

3.3. Data Validation

3.4 Primary Interviews

4. Market Dynamics Impact Analysis

4.1 Market Driving Factors Analysis

4.1.1 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

4.2 PESTLE Analysis

4.3 Porter’s Five Forces Model

5. Statistical Insights and Trends Reporting

5.1 AI Integration Rate in Pharma R&D (2024)

5.2 AI Investment Trends in Pharma (2024), by Region

 

5.3 AI-Powered Drug Discovery Output, by Region (2020–2032)

5.4 AI Software and Platform Adoption, by Deployment Type (Cloud vs. On-Premises), 2024

6. Competitive Landscape

6.1 List of Major Companies By Region

6.2 Market Share Analysis By Region

6.3 Product Benchmarking

6.3.1 Product specifications and features

6.3.2 Pricing

6.4 Strategic Initiatives

6.4.1 Marketing and promotional activities

6.4.2 Distribution and Supply Chain Strategies

6.4.3 Expansion plans and new product launches

6.4.4 Strategic partnerships and collaborations

6.5 Technological Advancements

6.6 Market Positioning and Branding

7. Artificial Intelligence (AI) in Pharmaceutical Market Segmentation By Application

7.1 Chapter Overview

7.2 Drug Discovery

7.2.1 Drug Discovery Market Trends Analysis (2021-2032)

7.2.2 Drug Discovery Market Size Estimates and Forecasts to 2032 (USD Billion)

7.3 Precision Medicine

7.3.1 Precision Medicine Market Trends Analysis (2021-2032)

7.3.2 Precision Medicine Market Size Estimates and Forecasts to 2032 (USD Billion)

7.4 Medical Imaging & Diagnostics

7.4.1 Medical Imaging & Diagnostics Market Trends Analysis (2021-2032)

7.4.2 Medical Imaging & Diagnostics Market Size Estimates and Forecasts to 2032 (USD Billion)

7.5 Research

7.5.1 Research Market Trends Analysis (2021-2032)

7.5.2 Research Market Size Estimates and Forecasts to 2032 (USD Billion)

8. Artificial Intelligence (AI) in Pharmaceutical Market Segmentation By Technology

8.1 Chapter Overview

8.2 Machine Learning

8.2.1 Machine Learning Market Trends Analysis (2021-2032)

8.2.2 Machine Learning Market Size Estimates and Forecasts to 2032 (USD Billion)

8.3 Natural Language Processing

         8.3.1 Natural Language Processing Market Trends Analysis (2021-2032)

8.3.2 Natural Language Processing Market Size Estimates and Forecasts to 2032 (USD Billion)

8.4 Deep Learning

         8.4.1 Deep Learning Market Trends Analysis (2021-2032)

8.4.2 Deep Learning Market Size Estimates and Forecasts to 2032 (USD Billion)

8.5 Others

         8.5.1 Other Market Trends Analysis (2021-2032)

8.5.2 Others Market Size Estimates and Forecasts To 2032 (USD Billion)

9. Artificial Intelligence (AI) in Pharmaceutical Market Segmentation By Offering

9.1 Chapter Overview

9.2 Hardware

9.2.1 Hardware Market Trends Analysis (2021-2032)

9.2.2 Hardware Market Size Estimates and Forecasts to 2032 (USD Billion)

9.3 Software

9.3.1 Software Market Trends Analysis (2021-2032)

9.3.2 Software Market Size Estimates and Forecasts to 2032 (USD Billion)

9.4 Services

9.4.1 Services Market Trends Analysis (2021-2032)

9.4.2 Services Market Size Estimates and Forecasts to 2032 (USD Billion)

10. Artificial Intelligence (AI) in Pharmaceutical Market Segmentation By Deployment

10.1 Chapter Overview

10.2 Cloud

10.2.1 Cloud Market Trends Analysis (2021-2032)

10.2.2 Cloud Market Size Estimates and Forecasts to 2032 (USD Billion)

10.3 On-Premises

10.3.1 On-Premises Market Trend Analysis (2021-2032)

10.3.2 On-Premises Market Size Estimates and Forecasts to 2032 (USD Billion)

11. Regional Analysis

11.1 Chapter Overview

11.2 North America

11.2.1 Trend Analysis

11.2.2 North America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Country (2021-2032) (USD Billion)

11.2.3 North America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion) 

11.2.4 North America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.2.5 North America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.2.6 North America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.2.7 USA

11.2.7.1 USA Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.2.7.2 USA Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.2.7.3 USA Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.2.7.4 USA Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.2.8 Canada

11.2.8.1 Canada Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.2.8.2 Canada Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.2.8.3 Canada Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.2.8.4 Canada Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.2.9 Mexico

11.2.9.1 Mexico Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.2.9.2 Mexico Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.2.9.3 Mexico Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.2.9.4 Mexico Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.3 Europe

11.3.1 Trend Analysis

11.3.2 Europe Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Country (2021-2032) (USD Billion)

11.3.3 Europe Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion) 

11.3.4 Europe Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.3.5 Europe Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.3.6 Europe Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.3.7 Germany

11.3.7.1 Germany Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.3.7.2 Germany Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.3.7.3 Germany Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.3.7.4 Germany Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.3.8 France

11.3.8.1 France Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.3.8.2 France Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.3.8.3 France Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.3.8.4 France Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.3.9 UK

11.3.9.1 UK Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.3.9.2 UK Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.3.9.3 UK Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.3.9.4 UK Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment  (2021-2032) (USD Billion)

11.3.10 Italy

11.3.10.1 Italy Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.3.10.2 Italy Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.3.10.3 Italy Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.3.10.4 Italy Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.3.11 Spain

11.3.11.1 Spain Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.3.11.2 Spain Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.3.11.3 Spain Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.3.11.4 Spain Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.3.12 Poland

11.3.12.1 Poland Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.3.12.2 Poland Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.3.12.3 Poland Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.3.12.4 Poland Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.3.13 Turkey

11.3.13.1 Turkey Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.3.13.2 Turkey Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.3.13.3 Turkey Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.3.13.4 Turkey Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.3.14 Rest of Europe

11.3.14.1 Rest of Europe Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.3.14.2 Rest of Europe Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.3.14.3 Rest of Europe Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.3.14.4 Rest of Europe Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.4 Asia Pacific

11.4.1 Trend Analysis

11.4.2 Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Country (2021-2032) (USD Billion)

11.4.3 Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion) 

11.4.4 Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.4.5 Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.4.6 Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.4.7 China

11.4.7.1 China Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.4.7.2 China Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.4.7.3 China Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.4.7.4 China Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.4.8 India

11.4.8.1 India Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.4.8.2 India Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.4.8.3 India Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.4.8.4 India Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.4.9 Japan

11.4.9.1 Japan Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.4.9.2 Japan Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.4.9.3 Japan Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.4.9.4 Japan Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.4.10 South Korea

11.4.10.1 South Korea Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.4.10.2 South Korea Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.4.10.3 South Korea Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.4.10.4 South Korea Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.4.11 Singapore

11.4.11.1 Singapore Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.4.11.2 Singapore Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.4.11.3 Singapore Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.4.11.4 Singapore Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.4.12 Australia

11.4.12.1 Australia Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.4.12.2 Australia Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.4.12.3 Australia Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.4.12.4 Australia Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.4.13 Rest of Asia Pacific

11.4.13.1 Rest of Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.4.13.2 Rest of Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.4.13.3 Rest of Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.4.13.4 Rest of Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.5 Middle East and Africa

11.5.1 Trend Analysis

11.5.2 Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Country (2021-2032) (USD Billion)

11.5.3 Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion) 

11.5.4 Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.5.5 Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.5.6 Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.5.7 UAE

11.5.7.1 UAE Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.5.7.2 UAE Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.5.7.3 UAE Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.5.7.4 UAE Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.5.8 Saudi Arabia

11.5.8.1 Saudi Arabia Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.5.8.2 Saudi Arabia Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.5.8.3 Saudi Arabia Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.5.8.4 Saudi Arabia Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.5.9 Qatar

                     11.5.9.1 Qatar Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.5.9.2 Qatar Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.5.9.3 Qatar Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.5.1.9.4 Qatar Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.5.10   South Africa

11.5.10.1 South Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.5.10.2 South Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.5.10.3 South Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.5.10.4 South Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.5.11 Rest of Middle East & Africa

                    11.5.11.1 Rest of Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.5.11.2 Rest of Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.5.11.3 Rest of Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.5.11.4 Rest of Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.6 Latin America

11.6.1 Trend Analysis

11.6.2 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Country (2021-2032) (USD Billion)

11.6.3 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion) 

11.6.4 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.6.5 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.6.6 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.6.7 Brazil

11.6.7.1 Brazil Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.6.7.2 Brazil Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.6.7.3 Brazil Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.6.7.4 Brazil Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.6.8 Argentina

11.6.8.1 Argentina Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.6.8.2 Argentina Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.6.8.3 Argentina Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.6.8.4 Argentina Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

11.6.9 Rest of Latin America

11.6.9.1 Rest of Latin America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Application (2021-2032) (USD Billion)

11.6.9.2 Rest of Latin America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Technology (2021-2032) (USD Billion)

11.6.9.3 Rest of Latin America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts By Offering (2021-2032) (USD Billion)

11.6.9.4 Rest of Latin America Artificial Intelligence (AI) in Pharmaceutical Market Estimates and Forecasts by Deployment (2021-2032) (USD Billion)

12. Company Profiles

12.1 IBM Watson Health

          12.1.1 Company Overview

12.1.2 Financial

12.1.3 Products/ Services Offered

12.1.4 SWOT Analysis

12.2 Google DeepMind

           12.2.1 Company Overview

12.2.2 Financial

12.2.3 Products/ Services Offered

12.2.4 SWOT Analysis

12.3 Isomorphic Labs           

          12.3.1 Company Overview

12.3.2 Financial

12.3.3 Products/ Services Offered

12.3.4 SWOT Analysis

12.4 Microsoft Corporation

          12.4.1 Company Overview

12.4.2 Financial

12.4.3 Products/ Services Offered

12.4.4 SWOT Analysis

12.5 NVIDIA Corporation

          12.5.1 Company Overview

12.5.2 Financial

12.5.3 Products/ Services Offered

12.5.4 SWOT Analysis

12.6 Insilico Medicine

            12.6.1 Company Overview

12.6.2 Financial

12.6.3 Products/ Services Offered

12.6.4 SWOT Analysis

12.7 Exscientia

          12.7.1 Company Overview

12.7.2 Financial

12.7.3 Products/ Services Offered

12.7.4 SWOT Analysis

12.8 Recursion Pharmaceuticals

12.8.1 Company Overview

12.8.2 Financial

12.8.3 Products/ Services Offered

12.8.4 SWOT Analysis

12.9 BenevolentAI

12.9.1 Company Overview

12.9.2 Financial

12.9.3 Products/ Services Offered

12.9.4 SWOT Analysis

12.10 BioXcel Therapeutics

12.10.1 Company Overview

12.10.2 Financial

12.10.3 Products/ Services Offered

12.10.4 SWOT Analysis

13. Use Cases and Best Practices

14. Conclusion